港股異動 | 思摩爾國際(6969.HK)續漲5.3% 股價再創新高
格隆匯12月18日丨入選了格隆匯2021年“下注中國十大核心資產”名單的思摩爾國際(6969.HK)今日再度走強,盤中最高見54.9港元續創歷史新高,現報54.5港元,漲幅5.31%,最新總市值3194.24億港元,近6個交易日累計漲超18%。國元國際研報指,鑑於客户與技術構築雙壁壘,首次覆蓋予買入評級,目標價58.6港元。報告指出,新型煙草進入高速發展的黃金時代,公司目前擁有10個生產基地,產能持續擴張,並且在電子霧化行業中首次實現了封閉式POD產品的全工藝流程自動化,工藝領先。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.